June 2013 JPGN Articles
1 - All of these explanations have been suggested to contribute to the development of esophageal dysmotility in EA patients, except :
A   - Postoperative complications
B   - Surgical manipulations
C   - Intrinsic nerve developmental abnormalities
D   - EA type (according to Haight classification)
2 - Which of the following condition(s) should be excluded prior to diagnosing esophageal dysmotility in a patient with EA post-repair?
A   - Esophagitis
B   - GERD
C   - Fundoplication dysfunction
D   - All of the above
3 - Which of the following is correct about HREM evaluation in EA operated patients?
A   - Esophageal motility is normal in most patients
B   - Esophageal motility pattern was the same for all patients
C   - Upper esophageal sphincter relaxation is normal in most patients
D   - Lower esophageal sphincter basal pressure is high in most patients
4 - Regarding EA operated patients' symptomatology, which is true?
A   - Symptoms correlated with the severity of esophageal dysmotility
B   - GERD symptoms were the most frequent GI complaints
C   - Change in alimentary habits were not frequently encountered
D   - Asymptomatic patients were found in all 3 types of EA motility patterns
5 - Which of the following was the most common adverse event associated with FMT
A   - Bloating / flatulence / diarrhea
B   - Blood in stool
C   - Nausea
D   - Fever
6 - The average amount of fecal enema tolerated by children with ulcerative colitis was
A   - 45 ml
B   - 165 ml
C   - 225 ml
D   - 90 ml
7 - To screen donors for FMT, this study performed blood and stool tests to rule out infectious pathogens and used a donor history questionnaire provided by
A   - American Gastroenterological Association
B   - American Association of Blood Banks
C   - The local IRB
D   - Infectious disease department
8 - Which of the following is a true statement based on this study?
A   - Majority of patients had clinical remission with FMT
B   - Patients with severe disease were also included in the study
C   - Majority of patients had clinical response with FMT
D   - At 1 month, most responders had relapsed